{"DataElement":{"publicId":"2321527","version":"1","preferredName":"Fluorodeoxyglucose Positron Emission Tomography Planned Injection Amount","preferredDefinition":"a prepared dose or volume of a radioactive form of glucose filled in a syringe and needle for injection during diagnostic imaging with positron emission tomography.","longName":"FDG_PET_P_INJEC_AMT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2321518","version":"1","preferredName":"Fluorodeoxyglucose Positron Emission Tomography Planned Injection","preferredDefinition":"information relating to the prepared amount of a radioactive form of glucose filled in a syringe and needle for a diagnostic imaging procedure with positron emission tomography.","longName":"FDG_PET_P_INJECT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2321504","version":"1","preferredName":"Fludeoxyglucose F 18 Positron Emission Tomography","preferredDefinition":"The radioactive form of glucose used in positron emission tomography (PET), a diagnostic imaging procedure.:A noninvasive imaging method that provides information about cellular activity (metabolic information).  It is used along with magnetic resonance imaging (MRI) which provides information about the shape and size of the tumor (spatial information).","longName":"C964:C17007","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fludeoxyglucose F-18","conceptCode":"C964","definition":"A positron-emitting radiopharmaceutical containing radioactive 2-deoxy-2-[18F] fluoro-D-glucose. With similar cell uptake as glucose (high in tumor cells), fludeoxyglucose F 18 is not dephosphorylated and further metabolized. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-2131-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"PWEST","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321516","version":"1","preferredName":"Planned Injection","preferredDefinition":"Planned; devised, contrived, or formed in design.:Use of a syringe and needle to push fluids or drugs into the body; often called a \"shot.\"","longName":"C25619:C0021485","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plan","conceptCode":"C25619","definition":"To devise, contrive, or form in design.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Injection","conceptCode":"C0021485","definition":"Use of a syringe and needle to push fluids or drugs into the body; often called a \"shot.\"","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-00AD-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"PWEST","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-00AE-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"PWEST","dateCreated":"2005-07-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2321523","version":"1","preferredName":"Fluorodeoxyglucose Positron Emission Tomography Injection Amount","preferredDefinition":"a dose or volume of a radioactive form of glucose for injection during diagnostic imaging with positron emission tomography.","longName":"FDG_PET_INJECT_AMT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2459817","version":"1","preferredName":"Amount","preferredDefinition":"The total quantity or number.","longName":"C25417","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Amount","conceptCode":"C25417","definition":"The total quantity or number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F0AEBD7-98B5-60D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-16","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-16","modifiedBy":"ONEDATA","dateModified":"2006-03-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0FECE0-3089-015B-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"PWEST","dateCreated":"2005-07-29","modifiedBy":"DWARZEL","dateModified":"2007-02-13","changeDescription":"Units in microCuries","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Amount of FDG in Syringe Pre-","type":"Preferred Question Text","description":"Amount of FDG in Syringe Pre-Injection","url":null,"context":"CTEP"},{"name":"1-COMMENT","type":"COMMENT","description":"Units in mCi","url":null,"context":"CTEP"}],"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FD108DA0-A4B5-0EFE-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"PWEST","dateCreated":"2005-07-29","modifiedBy":"ALAIS","dateModified":"2008-12-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}